CHICAGO EQUITY PARTNERS LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 213 filers reported holding IMMUNOGEN INC in Q3 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$437,000
+41.9%
85,660
-32.7%
0.02%
+66.7%
Q3 2019$308,000
-35.0%
127,305
+154.6%
0.02%
+7.1%
Q3 2018$474,000
-90.7%
50,006
-90.5%
0.01%
-91.1%
Q2 2018$5,124,000
-3.3%
526,660
+4.5%
0.16%
-7.1%
Q1 2018$5,300,000
+69.1%
503,765
+3.0%
0.17%
+76.0%
Q4 2017$3,135,000
-16.5%
489,035
-0.3%
0.10%
-19.3%
Q3 2017$3,753,000
+141.8%
490,635
+124.7%
0.12%
+183.3%
Q2 2017$1,552,000218,3200.04%
Other shareholders
IMMUNOGEN INC shareholders Q3 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders